Immunopathological Analysis in a French National Cohort of Membranous Nephropathy (IHMN)
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
National cohort of all cases of membranous nephropathy (MN) during a 1 year period in France, based on a pathological and/or serological diagnostic, collecting the data on: * incidence of MN * prevalence of anti-PLA2R1 and anti-THSD7A * clinical outcome one year after diagnosis or after relapse (complete remission, partial remission or persistent nephrotic syndrome) * environmental risk factors for the onset of MN * HLA markers * patient care status in France
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age 18 years or more
• Biopsy on a native kidney consistent with MN and/or positivity for serum anti-PLA2R1 and/or anti-THSD7A antibodies
• Signed informed consent
Locations
Other Locations
France
CHU de Nice, Hôpital de l'Archet
RECRUITING
Nice
Contact Information
Primary
Barbara SEITZ-POLSKI, MD
seitz-polski.b@chu-nice.fr
+33 4 92 03 55 02
Time Frame
Start Date: 2020-07-04
Estimated Completion Date: 2031-12-03
Participants
Target number of participants: 400
Treatments
Other: Cohort
All patients included will have to be taken blood samples
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Universitaire de Nice